Stevanato Group S.p.A STVN
NYSE STVN
$20.17 +0.22 (+1.10%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stevanato Group S.p.A (STVN) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Stevanato Group S.p.A (STVN) reported Return on Capital Employed [ROCE] of 8.11% for the quarter ended Jun 30, 2026, up 0.01 percentage points from 8.09% a year earlier but down 0.18 percentage points from the prior quarter.

Analysis

Stevanato Group S.p.A (STVN) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Stevanato Group S.p.A posted Return on Capital Employed [ROCE] of 8.91%, up 1.17 percentage points from the prior year.

  • Return on Capital Employed [ROCE] has a four-year change of -5.44 percentage points (years ended Dec 2021 to Dec 2025).
  • By year, Return on Capital Employed [ROCE] came in at 7.74% in the year ended Dec 31, 2024 (-4.06 pp), 11.80% in the year ended Dec 31, 2023 (-0.57 pp), 12.37% in the year ended Dec 31, 2022 (-1.98 pp) and 14.35% in the year ended Dec 31, 2021.
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of 7.41% in the quarter ended Sep 30, 2024 and a high of 18.07% in the quarter ended Sep 30, 2021.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last five quarters, with an average year-over-year change of -0.75 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was the quarter ended Dec 31, 2025 (a gain of 0.79 percentage points); the low point was the quarter ended Sep 30, 2022 (a drop of 6.14 percentage points).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 8.28% (quarter ended Mar 31, 2026), 8.24% (quarter ended Dec 31, 2025) and 8.19% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 8.30%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 7.98%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 6.42%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 18.58%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 8.34%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 13.69%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 10.83%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 11.99%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 6.00%
10 Stevanato Group S.p.A 6.11 Bn 5.55 Bn 100.91 Mn 8.11%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.11%
Mar 31, 2026 8.28%
Dec 31, 2025 8.24%
Sep 30, 2025 8.19%
Jun 30, 2025 8.09%
Mar 31, 2025 7.69%
Dec 31, 2024 7.45%
Sep 30, 2024 7.41%
Jun 30, 2024 7.87%
Mar 31, 2024 9.08%
Dec 31, 2023 10.80%
Sep 30, 2023 11.05%
Jun 30, 2023 11.10%
Mar 31, 2023 11.99%
Dec 31, 2022 12.64%
Sep 30, 2022 11.93%
Jun 30, 2022 10.92%
Mar 31, 2022 11.63%
Dec 31, 2021 12.19%
Sep 30, 2021 18.07%
API Access

Stevanato Group S.p.A Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=STVN&period=max&api_key=YOUR_API_KEY